Remove 2030 Remove Dosage Remove Packaging
article thumbnail

3 of the year’s most notable FDA nods

PharmaVoice

Other PrEP regimens on the market require daily oral dosages or shots every few months, but the latest version is only administered twice a year. Now, the WHO’s aggressive goal to “ end HIV/AIDS ” by 2030 could be hampered by dramatic reductions in U.S. While Enhertu pulled in about $3.8

FDA 130
article thumbnail

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

PharmTech

Shifts in sterile manufacturing include isolator tech adoption and packaging tailored to personalized medicine, at-home use, and chronic disease treatments. The collaboration emphasizes standardization and regulatory-compliant development of RTU platforms to improve efficiency in sterile fill/finish processes.

Dosage 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advancements in Biopharma Spur Innovation

PharmTech

The global biopharma industry is expected to increase at a compound annual growth rate of 8.97% from 2025 to 2030; this growth is suspected to result from a demand for targeted therapies, new alliances, and increased innovation (1).

Dosage 52
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

article thumbnail

Elkedonia Raises €11.25M Seed Round to Advance Neuroplastogen Therapy for Depression

PharmTech

The financing round was co-led by Kurma Partners , WE Life Sciences , and the French Tech Seed Fund managed by Bpifrance , on behalf of the French government, under the France 2030 initiative. Additional participants included Argobio , Angelini Ventures , CARMA Fund , Capital Grand Est , and Sambrinvest.

Dosage 52